Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
mdx-1303 (Valortim) (1 trial)
Hypersensitivity (Phase 1)
Trials (1 total)
Trial APIs (1 total)